SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 138 filers reported holding SCICLONE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $800,000 | -9.7% | 71,331 | -11.5% | 0.00% | – |
| Q2 2017 | $886,000 | +9.9% | 80,593 | -2.0% | 0.00% | – |
| Q1 2017 | $806,000 | +74.5% | 82,277 | +92.4% | 0.00% | – |
| Q4 2016 | $462,000 | +600.0% | 42,769 | +565.9% | 0.00% | – |
| Q3 2016 | $66,000 | -40.0% | 6,423 | -24.0% | 0.00% | – |
| Q2 2016 | $110,000 | -29.9% | 8,448 | -40.7% | 0.00% | – |
| Q1 2016 | $157,000 | +12.1% | 14,237 | -6.6% | 0.00% | – |
| Q4 2015 | $140,000 | -37.5% | 15,243 | -52.7% | 0.00% | – |
| Q3 2015 | $224,000 | -41.8% | 32,258 | -17.6% | 0.00% | – |
| Q2 2015 | $385,000 | +36.0% | 39,163 | +22.8% | 0.00% | – |
| Q1 2015 | $283,000 | -6.6% | 31,879 | -7.7% | 0.00% | – |
| Q4 2014 | $303,000 | +3.4% | 34,520 | -18.9% | 0.00% | – |
| Q3 2014 | $293,000 | -66.0% | 42,583 | -74.0% | 0.00% | – |
| Q2 2014 | $861,000 | +31.9% | 163,502 | +13.9% | 0.00% | – |
| Q1 2014 | $653,000 | -9.7% | 143,602 | +0.1% | 0.00% | – |
| Q4 2013 | $723,000 | -4.9% | 143,477 | -4.3% | 0.00% | – |
| Q3 2013 | $760,000 | -11.0% | 149,978 | -12.9% | 0.00% | – |
| Q2 2013 | $854,000 | – | 172,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|